Achat d’initiés au cours des 6 derniers mois | Titres | Trans. |
---|---|---|
Achats | 243 243 | 6 |
Ventes | 420 663 | 1 |
Titres nets achetés (vendus) | -177 420 | 7 |
Total des titres d’initiés détenus | 1,15M | S.O. |
% des titres nets acquis (vendus) | -13,40 % | S.O. |
Achats institutionnels nets à partir du trimestre précédent jusqu’au dernier trimestre | Titres |
---|---|
Titres nets achetés (vendus) | S.O. |
% de variation dans les titres institutionnels détenus | S.O. |
Initié | Transaction | Type | Valeur | Date | Titres |
---|---|---|---|---|---|
VIVO OPPORTUNITY LLC | Sale at price 6.20 - 6.99 per share. | Indirect | 2 796 859 | 03 avr. 2024 | 420 663 |
YOON SEOKHO BRYAN | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | 23 janv. 2024 | 68 750 |
VIGNOLA MARK J. | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | 23 janv. 2024 | 68 750 |
QUIGLEY JILL M. | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | 23 janv. 2024 | 15 000 |
QUIRK ERIN M.D. | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | 23 janv. 2024 | 75 000 |
YOON SEOKHO BRYAN | Purchase at price 3.78 per share. | Direct | 2 809 | 30 nov. 2023 | 743 |
QUIGLEY JILL M. | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | 15 nov. 2023 | 15 000 |
SUNDARAM SENTHIL VEL | Purchase at price 10.61 per share. | Direct | 22 398 | 31 mai 2023 | 2 111 |
YOON SEOKHO BRYAN | Purchase at price 10.61 per share. | Direct | 106 068 | 31 mai 2023 | 9 997 |
GORDON CARL L | Purchase at price 7.25 per share. | Indirect | 1 000 000 | 23 déc. 2022 | 137 931 |
ORBIMED ADVISORS, L.L.C. | Purchase at price 7.25 per share. | Indirect | 1 000 000 | 23 déc. 2022 | 137 931 |
LU HONGBO B | Purchase at price 7.25 per share. | Indirect | 5 499 995 | 23 déc. 2022 | 758 620 |
VIVO OPPORTUNITY LLC | Purchase at price 7.25 per share. | Indirect | 5 499 995 | 23 déc. 2022 | 758 620 |
SUNDARAM SENTHIL VEL | Purchase at price 7.77 per share. | Direct | 23 | 30 nov. 2022 | 3 |
YOON SEOKHO BRYAN | Purchase at price 7.77 per share. | Direct | 23 | 30 nov. 2022 | 3 |
VIGNOLA MARK J. | Purchase at price 7.77 per share. | Direct | 23 | 30 nov. 2022 | 3 |
LAV BIOSCIENCES FUND V LP | Sale at price 5.50 per share. | Indirect | 8 250 000 | 23 nov. 2022 | 1 500 000 |
LU HONGBO B | Purchase at price 3.60 per share. | Indirect | 2 160 000 | 07 sept. 2022 | 600 000 |
VIVO OPPORTUNITY LLC | Purchase at price 3.60 per share. | Indirect | 2 160 000 | 07 sept. 2022 | 600 000 |
GORDON CARL L | Purchase at price 4.98 per share. | Indirect | 18 376 200 | 16 août 2022 | 3 690 000 |
ORBIMED ADVISORS, L.L.C. | Purchase at price 4.98 per share. | Indirect | 18 376 200 | 16 août 2022 | 3 690 000 |
LU HONGBO B | Purchase at price 2.98 - 4.98 per share. | Indirect | 10 821 962 | 16 août 2022 | 2 624 239 |
VIVO OPPORTUNITY LLC | Purchase at price 2.98 - 4.98 per share. | Indirect | 10 821 962 | 16 août 2022 | 2 624 239 |
YOON SEOKHO BRYAN | Purchase at price 1.47 per share. | Direct | 11 254 | 31 mai 2022 | 7 656 |
VIGNOLA MARK J. | Purchase at price 1.47 per share. | Direct | 11 254 | 31 mai 2022 | 7 656 |
GORDON CARL L | Purchase at price 17.00 per share. | Indirect | 8 075 000 | 09 févr. 2021 | 475 000 |
GORDON CARL L | Indirect | 09 févr. 2021 | 3 316 204 | ||
VIVO CAPITAL VIII, L.L.C. | Purchase at price 17.00 per share. | Indirect | 8 075 000 | 09 févr. 2021 | 475 000 |
VIVO CAPITAL VIII, L.L.C. | Indirect | 09 févr. 2021 | 2 200 133 | ||
ORBIMED ADVISORS, L.L.C. | Purchase at price 17.00 per share. | Indirect | 8 075 000 | 09 févr. 2021 | 475 000 |
ORBIMED ADVISORS, L.L.C. | Indirect | 09 févr. 2021 | 3 316 204 | ||
FLYNN JAMES E | Purchase at price 17.00 per share. | Indirect | 11 305 000 | 09 févr. 2021 | 665 000 |
FLYNN JAMES E | Indirect | 09 févr. 2021 | 1 717 033 | ||
LAV BIOSCIENCES FUND V LP | Indirect | 09 févr. 2021 | 4 781 566 |